NAS10030,732+0.82%S&P7,765GOLD$4,396+0.29%BTC$86,250−0.41%VIX14.21−4.44%live tape · as of 21:00 UTC
The Screen · Industrials · Specialty Industrial Machinery
GE Vernova
GEV · a US exchange · USD · Market cap $254.3B · 78,000 employees
GE Vernova Inc., an energy company, engages in the provision of various products and services that generate, transfer, orchestrate, convert, and store electricity in the United States, Europe, Asia, the Middle East, and Africa.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price946.22 USD
Fair value877.76
Ethical score88.6/100
RatingOVERVALUED
Our investment reviews on this name
2026-08-23Read Distribution966.01-2.0% to today ✓
2026-07-02Read Markdown933.61+1.4% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
GE Vernova holds its Distribution at $946.22. Consolidating, no directional conviction, held for 23 days.
As held on the ledger · 2026-09-21
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 23 days
Price at the screen
$946.22
Valuation
27.15 trailing · 37.44 forward price to earnings
Values screen
PASS· score 88.6
Beta
0.97
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
1.86%
Below 33%
Interest-bearing debt is just 1.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
2.91%
Below 33%
Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit.
Pass
Receivables
26.52%
Below 49%
Money owed to the company is 26.5% of assets, under the 49% limit.
Pass
Revenue purity
1.20%
Below 5%
Only 1.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades above our $877.76 fair value estimate, strong competitive moat, 21.90% revenue growth.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 7.2% above the base estimate.
Third-party analyst targets: 33 covering, consensus Buy. The average target sits +32% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
GE Vernova's Glow Fades Amid Overvaluation
Imagine a power grid that not only illuminates homes but also powers industries, a task GE Vernova Inc. takes on as it generates and transfers electricity across continents. Its strong moat, evidenced by a robust 23% profit margin and an impressive 83% return on equity, is a testament to its industry dominance. Why it stands out is not just its global reach but also its 22% revenue growth, painting a picture of a company at the forefront of the energy transition.
However, despite its strengths, the market is currently pricing GE Vernova at a forward P/E of 38.5x, which our analysis deems overvalued with a fair value of $876.10, suggesting a -9% margin of safety. While 33 analysts have a consensus buy rating and a median target of $1250, the numbers suggest caution. The risk here is the potential for a cyclical value trap, where the high P/E ratio might reflect peak earnings, signaling a warning rather than a bargain.
Lastly, GE Vernova passes our ethical screen, adhering to our standards. Yet, with the stock trading at $966.01, above our fair value, the risk of overvaluation is paramount. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GEV trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217.
2026-07-22Markdown$1,057.84+0.0%Entry 9
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markdown$1,057.84+0.0%Entry 8
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Markdown$1,057.84+0.0%Entry 7
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Markdown$1,057.84+13.3%Entry 6
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 13.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markdown$933.61+0.0%Entry 5
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-17Markdown$933.61+0.0%Entry 4
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-16Markdown$933.61+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Markdown$933.61+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markdown$933.61Entry 1
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
